We will discover and verify disease-specific epigenetic regulators(DSER), and finally build a database of various human disease-specific epigenetic regulators. Ultimately, We will share the DSER database for application to disease treatment. We believe that inhibiting disease development by controlling the expression of various target genes at once through the epigenetic regulator will be more fundamental and beyond the limits of antibody therapy. In addition, We think that effective clinical application will be possible by using the DSER database.

Tae-Ryong (Tim) Riew, M.D., Ph.D. is an Assistant Professor in the Department of Anatomy at the Catholic University of Korea. He earned his M.D. and Ph.D. from the same institution, focusing on the pathophysiology of neurological diseases. His research explores the critical roles of non-neuronal cells, including neuroglial cells, the blood-brain barrier (BBB), and the meninges. By integrating multi-omics and multi-scale imaging techniques across animal models and human tissues, Dr. Riew seeks to bridge the gap between molecular mechanisms and tissue-level pathology. His ultimate goal is to develop transformative therapeutic strategies for intractable neurological disorders by modulating the brain’s protective barriers.